LOTUSEYE

Lotus Eye Hospital and Institute Limited

Eye care hospital offering cataract, refractive and retinal services

Healthcare›Healthcare›Healthcare Services›Hospital

lotuseye.org(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-10-16

Stock price
₹114.36
Market cap
238 Cr
Stock P/E
1592.9
P/B
3.95
Dividend yield
0.0%
ROE (FY26)
0.1%
ROCE (FY26)
1.1%
Operating margin (FY26)
-0.7%
Debt / equity (FY26)
0.19
OCF / EBITDA (FY26)
92.8%
OCF / EBITDA (3Y)
103.2%

Full years shown; sign in free for the trailing twelve months. Learn about these metrics →

Price & valuation

Share price and valuation multiples (P/E, P/B and more) over time.

Loading price history…

Compare with peers

Loading peers…

What you need to know

Lotus Eye Hospital and Institute provides eye-care services and related product sales to patients from hospitals headquartered in Coimbatore, and reports them as a single segment, "Eye Care related sales and services".

Company snapshot

24thBy market cap

Ranked among 24 companies in Hospital.

What we see

Positives
  • ✓103% of operating profit came in as cash over the last three years — profits are backed by real cash.
Concerns
  • ✗Net margin is very thin at 0.1% — little room for error if costs rise.
2 more signals from the filings.Sign in free to see them all

Statement tables · Standalone

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales13 Cr12 Cr11 Cr13 Cr13 Cr12 Cr12 Cr14 Cr13 Cr14 Cr14 Cr17 Cr
Operating expenses (approx.)11 Cr10 Cr10 Cr11 Cr12 Cr11 Cr12 Cr12 Cr12 Cr13 Cr13 Cr14 Cr
EBITDA2 Cr2 Cr0.76 Cr2 Cr1 Cr0.79 Cr-0.17 Cr1 Cr0.77 Cr0.66 Cr0.48 Cr3 Cr
OPM %14.3%13.1%7.0%12.9%8.9%6.4%-1.4%10.9%5.9%4.8%3.5%17.3%
Other income0.27 Cr0.35 Cr0.40 Cr0.31 Cr0.26 Cr0.22 Cr0.51 Cr0.19 Cr0.27 Cr0.24 Cr0.48 Cr0.21 Cr
Interest0.01 Cr0.04 Cr0.03 Cr0.06 Cr0.08 Cr0.13 Cr0.09 Cr0.12 Cr0.12 Cr0.29 Cr0.33 Cr0.51 Cr
Depreciation0.89 Cr0.98 Cr1 Cr1 Cr1 Cr1 Cr-0.58 Cr0.82 Cr0.85 Cr0.98 Cr1 Cr2 Cr
Profit before tax1 Cr0.90 Cr0.0054 Cr0.86 Cr0.11 Cr-0.43 Cr0.84 Cr0.73 Cr0.07 Cr-0.38 Cr-0.48 Cr1 Cr
Tax %28.3%26.9%-351.9%27.2%6.6%43.8%70.0%25.3%-58.6%30.5%33.6%39.2%
Net profit0.85 Cr0.66 Cr0.02 Cr0.62 Cr0.10 Cr-0.24 Cr0.25 Cr0.54 Cr0.12 Cr-0.26 Cr-0.32 Cr0.61 Cr
EPS (₹)₹0.41₹0.32₹0.01₹0.30₹0.05₹-0.11₹0.12₹0.26₹0.06₹-0.13₹-0.15₹0.30

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales34 Cr38 Cr38 Cr41 Cr32 Cr39 Cr47 Cr48 Cr50 Cr54 CrSign in free for the trailing twelve months
Operating expenses (approx.)31 Cr34 Cr35 Cr37 Cr29 Cr33 Cr39 Cr42 Cr46 Cr50 CrSign in free for the trailing twelve months
EBITDA3 Cr4 Cr3 Cr4 Cr4 Cr6 Cr8 Cr7 Cr3 Cr3 CrSign in free for the trailing twelve months
OPM %9.5%11.1%8.0%9.4%11.0%15.0%16.1%13.5%6.9%6.3%Sign in free for the trailing twelve months
Other income0.71 Cr0.86 Cr0.68 Cr0.90 Cr0.74 Cr0.89 Cr1 Cr1 Cr1 Cr1 CrSign in free for the trailing twelve months
Interest0.06 Cr0.05 Cr0.06 Cr0.07 Cr0.06 Cr0.13 Cr0.10 Cr0.10 Cr0.35 Cr0.86 CrSign in free for the trailing twelve months
Depreciation3 Cr3 Cr3 Cr2 Cr2 Cr3 Cr3 Cr4 Cr3 Cr4 CrSign in free for the trailing twelve months
Profit before tax0.42 Cr2 Cr0.63 Cr1 Cr2 Cr4 Cr6 Cr4 Cr1 Cr-0.05 CrSign in free for the trailing twelve months
Tax %-6.1%-2.6%-12.8%26.9%21.3%27.1%27.9%27.4%46.5%250.0%Sign in free for the trailing twelve months
Net profit0.44 Cr2 Cr0.71 Cr1 Cr2 Cr3 Cr4 Cr3 Cr0.74 Cr0.08 CrSign in free for the trailing twelve months
EPS (₹)₹0.21₹0.84₹0.33₹0.51₹0.51—₹1.96₹1.40₹0.36₹0.04Sign in free for the trailing twelve months
Dividend payout %————0.0%34.6%25.5%35.7%1.4%14.6%Sign in free for the trailing twelve months
Sign in free for the trailing twelve months

The latest four quarters added up, next to each full year

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital21 Cr21 Cr21 Cr21 Cr21 Cr21 Cr21 Cr21 Cr21 Cr21 Cr
Reserves29 Cr30 Cr29 Cr30 Cr32 Cr34 Cr37 Cr39 Cr39 Cr39 Cr
Borrowings0.48 Cr0.29 Cr0.09 Cr——1 Cr———11 Cr
Other liabilities4 Cr7 Cr6 Cr7 Cr7 Cr6 Cr6 Cr7 Cr10 Cr11 Cr
Total liabilities55 Cr58 Cr57 Cr58 Cr59 Cr62 Cr63 Cr67 Cr70 Cr83 Cr
Fixed assets (net)41 Cr42 Cr44 Cr42 Cr40 Cr44 Cr44 Cr46 Cr49 Cr59 Cr
CWIP0.65 Cr0.29 Cr0.29 Cr0 Cr0 Cr—0 Cr0.08 Cr0 Cr0.09 Cr
Investments——0 Cr0 Cr0 Cr0 Cr0 Cr0 Cr0 Cr0 Cr
Inventories2 Cr2 Cr2 Cr2 Cr2 Cr2 Cr3 Cr3 Cr4 Cr4 Cr
Trade receivables0.68 Cr1 Cr0.76 Cr0.66 Cr0.74 Cr0.62 Cr1 Cr1 Cr1 Cr1 Cr
Cash & bank-0.79 Cr0.02 Cr-0.23 Cr4 Cr5 Cr4 Cr4 Cr3 Cr2 Cr2 Cr
Other assets11 Cr12 Cr10 Cr9 Cr11 Cr11 Cr12 Cr14 Cr14 Cr16 Cr
Total assets55 Cr58 Cr57 Cr58 Cr59 Cr62 Cr63 Cr67 Cr70 Cr83 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity3 Cr6 Cr4 Cr5 Cr3 Cr4 Cr4 Cr6 Cr5 Cr3 Cr
Cash from investing-1 Cr-4 Cr-4 Cr-0.53 Cr0.49 Cr-4 Cr-2 Cr-5 Cr-4 Cr-12 Cr
Cash from financing-0.25 Cr-2 Cr-1 Cr0.13 Cr-0.33 Cr-2 Cr-2 Cr-3 Cr-2 Cr9 Cr
Net cash flow2 Cr0.41 Cr-1 Cr4 Cr3 Cr-1 Cr0.49 Cr-2 Cr-0.64 Cr-0.20 Cr
Free cash flow (OCF − Capex)2 Cr2 Cr-0.49 Cr2 Cr2 Cr-0.29 Cr1 Cr0.04 Cr0.12 Cr-10 Cr

Ratios

No data for this view.